Increased circulating concentrations of bioactive PTH 1-84 in patients with heart failure

D Gruson1, T Lepoutre, S A Ahn

  • 1Pôle de recherche en Endocrinologie, Diabète et Nutrition, Institut de Recherche Expérimentale et Clinique, Brussels, Belgium. damien.gruson@uclouvain.be

Insights

Circulating parathyroid hormone (PTH) 1-84 levels are elevated in heart failure (HF) patients. Higher PTH 1-84 levels correlate with HF severity and biomarkers indicating disease worsening.

Area of Science:

  • Cardiology
  • Endocrinology
  • Biomarkers

Background:

  • Parathyroid hormone (PTH) is linked to left ventricular hypertrophy.
  • Elevated PTH levels are associated with poor prognosis in heart failure (HF) patients.

Purpose of the Study:

  • To measure bioactive PTH 1-84 levels in HF patients using a third-generation assay.
  • To assess the association between PTH 1-84 levels and HF disease severity.
  • To determine the relationship between PTH 1-84 and HF worsening biomarkers.

Main Methods:

  • PTH 1-84 concentrations were measured in 76 HF patients and 49 healthy volunteers.
  • Circulating levels of Nt-proANP, BNP, Nt-proBNP, proBNP, and Big ET-1 were also quantified.

Main Results:

  • HF patients exhibited significantly higher PTH 1-84 levels compared to controls.
  • PTH 1-84 levels increased with New York Heart Association functional classes.
  • PTH 1-84 concentrations showed significant correlations with Nt-proANP, BNP, Nt-proBNP, proBNP, and Big ET-1.

Conclusions:

  • Bioactive PTH 1-84 levels are significantly elevated in HF patients.
  • Circulating PTH concentrations are related to HF severity and established biomarkers of disease progression.
Abstract

Related Concept Videos

Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
The Parathyroid Glands00:59

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...